Biogen, Inc. - Strategy, SWOT and Corporate Finance Report
Biogen, Inc. - Strategy, SWOT and Corporate Finance Report
Abstract
Summary
Biogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Biogen, Inc. (Biogen or 'the company') is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies in the areas of hematology, neurology and immunology. The company develops therapies for multiple sclerosis (MS), neuroimmunology movement disorders, including Parkinson's disease, Alzheimer’s disease (AD) and dementia, and neuromuscular disorders, including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). It also manufactures biosimilars of advanced biologics. The company markets its products under Flixabi, Benepali, Imraldi, Spinraza, Tecfidera, Avonex, Tysabri, Eylea, Gazyva, Fampyra, Plegridy and Fumaderm brand names. Biogen has business presence in the US, Asia and Europe. The company is headquartered in Weston, Massachusetts, the US.
Scope
- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Biogen, Inc.'s business structure, strategy and prospects.
Content
Table of Contents
Company Snapshot
Biogen, Inc.: Company Overview
Biogen, Inc.: Overview and Key Facts
Biogen, Inc.: Overview
Biogen, Inc.: Key Facts
Biogen, Inc.: Key Employees
Biogen, Inc.: Key Employee Biographies
Biogen, Inc.: Major Products and Services
Biogen, Inc.: Company History
Biogen, Inc.: Management Statement
Biogen, Inc.: Locations and Subsidiaries
Biogen, Inc.: Key Competitors
Biogen, Inc.: Company Analysis
Biogen, Inc.: Business Description
Biogen, Inc.: SWOT Analysis
Biogen, Inc.: SWOT Overview
Biogen, Inc.: Strengths
Biogen, Inc.: Weaknesses
Biogen, Inc.: Opportunities
Biogen, Inc.: Threats
Biogen, Inc.: Corporate Financial Deals Activity
Biogen, Inc.: Financial Deals Overview
Biogen, Inc.: Targets and Partners
Biogen, Inc.: Top Deals 2018 - 2022YTD*
Biogen, Inc.: Advisors
Biogen, Inc.: Top Legal Advisors
Biogen, Inc.: Top Financial Advisors
Biogen, Inc.: Mergers and Acquisitions
Biogen, Inc.: Corporate Venturing
Biogen, Inc.: Capital Raising
Biogen, Inc.: Partnership
Biogen, Inc.: Divestments
Biogen, Inc.: Recent Developments
Biogen, Inc.: News and Events Summary
Biogen, Inc.: Corporate Governance
Biogen, Inc.: Financial Performance
Biogen, Inc.: Market Developments
Biogen, Inc.: Research & Development
Biogen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List Of Tables
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Company History
Table 4: Biogen, Inc.: Locations and Subsidiaries
Table 5: Biogen, Inc.: Key Competitors
Table 6: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Biogen, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 8: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Biogen, Inc.: Targets and Partners
Table 10: Biogen, Inc.: Top Deals 2018 - 2022YTD*
Table 11: Biogen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Biogen, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 14: Biogen, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Table 15: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 16: Biogen, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Table 17: Biogen, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 18: Biogen, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 19: Biogen, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 20: Biogen, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 21: Biogen, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 22: Biogen, Inc.: Divestments by Geography (2018 - YTD*2022)
Table 23: Biogen, Inc.: News and Events Summary
Table 24: Biogen, Inc.: Corporate Governance
Table 25: Biogen, Inc.: Financial Performance
Table 26: Biogen, Inc.: Market Developments
Table 27: Biogen, Inc.: Research & Development
Table 28: Biogen, Inc.: Strategy and Operations
List Of Figures
Figure 1: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Biogen, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Biogen, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 5: Biogen, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Figure 6: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 7: Biogen, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 8: Biogen, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 9: Biogen, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 10: Biogen, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 11: Biogen, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 12: Biogen, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 13: Biogen, Inc.: Divestments by Geography (2018 - YTD*2022)
Summary
Biogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Biogen, Inc. (Biogen or 'the company') is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies in the areas of hematology, neurology and immunology. The company develops therapies for multiple sclerosis (MS), neuroimmunology movement disorders, including Parkinson's disease, Alzheimer’s disease (AD) and dementia, and neuromuscular disorders, including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). It also manufactures biosimilars of advanced biologics. The company markets its products under Flixabi, Benepali, Imraldi, Spinraza, Tecfidera, Avonex, Tysabri, Eylea, Gazyva, Fampyra, Plegridy and Fumaderm brand names. Biogen has business presence in the US, Asia and Europe. The company is headquartered in Weston, Massachusetts, the US.
Scope
- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Biogen, Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Biogen, Inc.: Company Overview
Biogen, Inc.: Overview and Key Facts
Biogen, Inc.: Overview
Biogen, Inc.: Key Facts
Biogen, Inc.: Key Employees
Biogen, Inc.: Key Employee Biographies
Biogen, Inc.: Major Products and Services
Biogen, Inc.: Company History
Biogen, Inc.: Management Statement
Biogen, Inc.: Locations and Subsidiaries
Biogen, Inc.: Key Competitors
Biogen, Inc.: Company Analysis
Biogen, Inc.: Business Description
Biogen, Inc.: SWOT Analysis
Biogen, Inc.: SWOT Overview
Biogen, Inc.: Strengths
Biogen, Inc.: Weaknesses
Biogen, Inc.: Opportunities
Biogen, Inc.: Threats
Biogen, Inc.: Corporate Financial Deals Activity
Biogen, Inc.: Financial Deals Overview
Biogen, Inc.: Targets and Partners
Biogen, Inc.: Top Deals 2018 - 2022YTD*
Biogen, Inc.: Advisors
Biogen, Inc.: Top Legal Advisors
Biogen, Inc.: Top Financial Advisors
Biogen, Inc.: Mergers and Acquisitions
Biogen, Inc.: Corporate Venturing
Biogen, Inc.: Capital Raising
Biogen, Inc.: Partnership
Biogen, Inc.: Divestments
Biogen, Inc.: Recent Developments
Biogen, Inc.: News and Events Summary
Biogen, Inc.: Corporate Governance
Biogen, Inc.: Financial Performance
Biogen, Inc.: Market Developments
Biogen, Inc.: Research & Development
Biogen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List Of Tables
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Company History
Table 4: Biogen, Inc.: Locations and Subsidiaries
Table 5: Biogen, Inc.: Key Competitors
Table 6: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Biogen, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 8: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Biogen, Inc.: Targets and Partners
Table 10: Biogen, Inc.: Top Deals 2018 - 2022YTD*
Table 11: Biogen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Biogen, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 14: Biogen, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Table 15: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 16: Biogen, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Table 17: Biogen, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 18: Biogen, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 19: Biogen, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 20: Biogen, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 21: Biogen, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 22: Biogen, Inc.: Divestments by Geography (2018 - YTD*2022)
Table 23: Biogen, Inc.: News and Events Summary
Table 24: Biogen, Inc.: Corporate Governance
Table 25: Biogen, Inc.: Financial Performance
Table 26: Biogen, Inc.: Market Developments
Table 27: Biogen, Inc.: Research & Development
Table 28: Biogen, Inc.: Strategy and Operations
List Of Figures
Figure 1: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Biogen, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Biogen, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 5: Biogen, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Figure 6: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 7: Biogen, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 8: Biogen, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 9: Biogen, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 10: Biogen, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 11: Biogen, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 12: Biogen, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 13: Biogen, Inc.: Divestments by Geography (2018 - YTD*2022)
Related Report
